<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23072515</PMID><DateCompleted><Year>2013</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><PubDate><Year>2012</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>RNA polymerase I-driven reverse genetics system for enterovirus 71 and its implications for vaccine production.</ArticleTitle><Pagination><StartPage>238</StartPage><MedlinePgn>238</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1743-422X-9-238</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Enterovirus 71 (EV71) is a virus that causes from mild hand, foot and mouth disease (HFMD) to severe neurological complications and deaths in infants and young children. Effective antiviral agents and vaccines against EV71 are not available. However, Vero cell-based chemically inactivated EV71 vaccines could be developed soon based on the success of inactivated polio vaccine. Like poliovirus, EV71 has a positive single-stranded RNA genome of about 7400 nucleotides which contains a single open reading frame (ORF) flanked by conserved and untranslated regions at both the 5' and 3' ends.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The universal amplification of the full length genome of EV71 regardless of its genetic diversity, and the subsequent construction of a human RNA polymerase I-driven reverse genetics (RG) system to produce pure virus stocks in Vero cell within 10 days were described. The rescued viruses were characterized by DNA sequencing, cytopathic effect (CPE) and indirect fluorescent assay (IFA) in comparison with the wild-type viruses. Moreover, the rescued viruses grew to high titers and retained the same immunogenicity as the wild-type viruses.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We have established a simplified method to rescue RG EV71 virus from diverse clinical isolates with detailed genetic information and to prepare virus stocks in only 10 days. This method could accelerate EV71 vaccine development.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Animal Health Biotechnology, Temasek Life Sciences Laboratory, National University of Singapore, 1 Research Link, Singapore 117604, Republic of Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiener</LastName><ForeName>Tanja K</ForeName><Initials>TK</Initials></Author><Author ValidYN="Y"><LastName>Kwang</LastName><ForeName>Jimmy</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.6</RegistryNumber><NameOfSubstance UI="D012318">RNA Polymerase I</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003588" MajorTopicYN="N">Cytopathogenic Effect, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019084" MajorTopicYN="N">Fluorescent Antibody Technique, Indirect</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012318" MajorTopicYN="N">RNA Polymerase I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059386" MajorTopicYN="N">Reverse Genetics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2012</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23072515</ArticleId><ArticleId IdType="pmc">PMC3493273</ArticleId><ArticleId IdType="doi">10.1186/1743-422X-9-238</ArticleId><ArticleId IdType="pii">1743-422X-9-238</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pallansch MA, Roos RP. In: Fields virology. 4. Knipe DM, Howley PM, Griffin DE, Martin MA, Lamb RA, Roizman B, editor. Philadelphia, PA: Lippincott Williams &amp; Wilkin; 2000. Enteroviruses: poliovirus, coxsackieviruses, echoviruses, and newer enteroviruses; pp. 723&#x2013;775. vol. 1.</Citation></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Mong HO. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10:778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Pallansch MA. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 1995;39:195&#x2013;205. doi: 10.1016/0168-1702(95)00087-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(95)00087-9</ArticleId><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee KK, Lam TT, Chan YF, Bible JM, Kamarulzaman A, Tong CY, Takebe Y, Pybus OG. Revolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol. 2010;84:3339&#x2013;3350. doi: 10.1128/JVI.01019-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01019-09</ArticleId><ArticleId IdType="pmc">PMC2838098</ArticleId><ArticleId IdType="pubmed">20089660</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Oberste MS, Alexander JP, Kennett ML, Pallansch MA. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol. 1999;73:9969&#x2013;9975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113047</ArticleId><ArticleId IdType="pubmed">10559310</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcminn P, Lindsay K, Perara D, Chan HM, Chan KP, Cardosa MJ. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol. 2001;75:7732&#x2013;7738. doi: 10.1128/JVI.75.16.7732-7738.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.16.7732-7738.2001</ArticleId><ArticleId IdType="pmc">PMC115010</ArticleId><ArticleId IdType="pubmed">11462047</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmonds P, Welch J. Frequency and dynamics of recombination within different species of human enteroviruses. J Virol. 2006;80:483&#x2013;493. doi: 10.1128/JVI.80.1.483-493.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.1.483-493.2006</ArticleId><ArticleId IdType="pmc">PMC1317522</ArticleId><ArticleId IdType="pubmed">16352572</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Zhang Q, Li J, Can W, Zhang JX, Zhang L, Zhang W, Shao ZJ, Yan Y. Analysis of recombination and natural selection in human enterovirus 71. Virol. 2010;398:251&#x2013;261. doi: 10.1016/j.virol.2009.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.12.007</ArticleId><ArticleId IdType="pubmed">20060995</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander JP, Baden L, Pallansch MA, Anderson LJ. Enterovirus 71 infections and neurologic disease-United States, 1977&#x2013;1991. J Infect Dis. 1994;169:905&#x2013;908. doi: 10.1093/infdis/169.4.905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/169.4.905</ArticleId><ArticleId IdType="pubmed">8133108</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis and management of human enterovirus 71 infection. Lancet Neurol. 2010;9:1097&#x2013;1105. doi: 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Qian Y, Wang SX, Serrano JG, Li W, Huang ZH, Lu S. EV71: an emerging infectious disease vaccine target in the far east? Vaccine. 2010;28:3516&#x2013;3521. doi: 10.1016/j.vaccine.2010.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2010.03.003</ArticleId><ArticleId IdType="pubmed">20304038</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong KC, Devi S, Cardosa MJ, Wong KT. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol. 2010;84:661&#x2013;665. doi: 10.1128/JVI.00999-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00999-09</ArticleId><ArticleId IdType="pmc">PMC2798416</ArticleId><ArticleId IdType="pubmed">19864378</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JY, Chang CP, Tsai HH, Lee CD, Lian WC, Su IJ, Sai IH, Liu CC, Chou AH, Lu YJ, Chen CY, Lee PH, Chiang JR, Chong PC. Selection and characterization of vaccine strain for enterovirus 71 vaccine development. Vaccine. 2012;30:703&#x2013;711. doi: 10.1016/j.vaccine.2011.11.087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.11.087</ArticleId><ArticleId IdType="pubmed">22142585</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Shimizu H, Nagata N, Ami Y, Suzaki Y, Sata T, Iwasaki T, Miyamura T. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J Gen Virol. 2005;86:1391&#x2013;1401. doi: 10.1099/vir.0.80784-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.80784-0</ArticleId><ArticleId IdType="pubmed">15831951</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JF, Cao RY, Tian X, Yu M, Qin ED, Qin CF. Producing infectious enterovirus type 71 in a rapid strategy. Virol J. 2010;7:116&#x2013;120. doi: 10.1186/1743-422X-7-116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-116</ArticleId><ArticleId IdType="pmc">PMC2892457</ArticleId><ArticleId IdType="pubmed">20525351</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. A DNA transfection system for generation of influenza a virus from eight plasmids. Proc Natl Acad Sci USA. 2000;97:6108&#x2013;6113. doi: 10.1073/pnas.100133697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.100133697</ArticleId><ArticleId IdType="pmc">PMC18566</ArticleId><ArticleId IdType="pubmed">10801978</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y, Zheng H, Shang Y, Jin Y, Wang G, Shen X, Liu X. Recovery of infectious foot-and-mouth disease virus from full-length genomic cDNA clones using RNA polymerase i system. Acta Biochem Biophys Sin. 2009;41:998&#x2013;1007. doi: 10.1093/abbs/gmp093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/abbs/gmp093</ArticleId><ArticleId IdType="pubmed">20011974</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng T, Kolpe AB, Kiener TK, Chow VT, Kwang J. Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in mice. PLoS One. 2011;6:e21757. doi: 10.1371/journal.pone.0021757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0021757</ArticleId><ArticleId IdType="pmc">PMC3128602</ArticleId><ArticleId IdType="pubmed">21747954</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Liu Z, Xie Q, Chen Y, Bao H, Chang H, Liu X. Generation of an infectious cDNA clone of an FMDV strain isolated from swine. Virus Res. 2004;104:157&#x2013;164. doi: 10.1016/j.virusres.2004.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2004.04.002</ArticleId><ArticleId IdType="pubmed">15246653</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu J, Stein S, Rosenstein L, Bodwell T, Routbort M, Semler BL, Ross RP. Neorovirulence determinants of genetically engineered Theiler viruses. Proc Nati Acad Sci USA. 1990;87:4125&#x2013;4129. doi: 10.1073/pnas.87.11.4125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.87.11.4125</ArticleId><ArticleId IdType="pmc">PMC54060</ArticleId><ArticleId IdType="pubmed">2161533</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins PR, Jin P, Fu GK. Full-length cDNA synthesis for long-distance RT-PCR of large mRNA transcripts. Biotechniques. 2003;34:768&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pubmed">12703302</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarnow P. Role of 3&#x2032;-end sequences in infectivity of poliovirus transcripts made in vitro. J Virol. 1989;63:467&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC247710</ArticleId><ArticleId IdType="pubmed">2535751</ArticleId></ArticleIdList></Reference><Reference><Citation>Janda M, French R, Ahlquist P. High efficiency T7 polymerase synthesis of infectious RNA from cloned brome mosaic virus cDNA and effects of 5&#x2032; entensions on transcript infectivity. Virology. 1987;158:259&#x2013;262. doi: 10.1016/0042-6822(87)90265-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(87)90265-0</ArticleId><ArticleId IdType="pubmed">18644564</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Guo MS, Lin FH, Hsiao KN, Chang KH, Chou AH, Wnag YC, Yang CS, Chong PC. Purification and characterization of enterovirus 71 viral particles produced from Vero cells grown in a serum-free microcarrier bioreactor system. PLoS One. 2011;6:e20005. doi: 10.1371/journal.pone.0020005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020005</ArticleId><ArticleId IdType="pmc">PMC3094384</ArticleId><ArticleId IdType="pubmed">21603631</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolson C, Major D, Wood JM, Robertson JS. Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine. 2005;23:2943&#x2013;2952. doi: 10.1016/j.vaccine.2004.08.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2004.08.054</ArticleId><ArticleId IdType="pubmed">15780743</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>